Bureau Veritas SA (BVI)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 29.21 |
|---|---|
| 52-week range | 24.58 – 30.18 |
| Return, 1 month / 3 months | +7.4% / +8.1% |
| Return, 1 year / 3 years | +5.7% / +41.4% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 24.0% |
| Worst drawdown (1 year) | -13.8% |
| Average daily value traded | 25.37M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bureau Veritas is a services company that tests, inspects and certifies products, equipment and facilities for clients across many industries. Its work covers areas such as construction, shipping, manufacturing, energy and consumer goods, where customers need independent checks that items meet safety, quality and regulatory standards. The company also offers training and technical consulting. It is based in France and operates through a broad international network of laboratories and offices serving businesses and public bodies.
Bureau Veritas SA trades under the code BVI on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bureau Veritas SA (BVI) trades on the Euronext Paris in France. It last closed at EUR 29.21 on 23 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 22 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.7% and over the last three months it rose 8.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.3% | ||
| From 52-week high | -0.9% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.1% | ||
| 6-month return | 18.2% | ||
| 12-month return, skipping the last month | -1.6% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.8% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 25.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | +7.4% |
| 3 months | +8.1% |
| 6 months | +18.2% |
| 1 year | +5.7% |
| 3 years | +41.4% |
| 5 years | +25.3% |
Signals
| 50-day / 200-day average | 27.41 / 26.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | EUR 0.9200 |
| 1 Jul 2025 | EUR 0.9000 |
| 2 Jul 2024 | EUR 0.8300 |
| 4 Jul 2023 | EUR 0.7700 |
| 5 Jul 2022 | EUR 0.5300 |
| 5 Jul 2021 | EUR 0.3600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.